NCT06281314Completed
The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive Impairment
VESPA 2.0 - Virtual Environment for a Superior Neuropsychiatry Second Generation
Source: ClinicalTrials.gov · Last updated 8 Mar 2024
Brief summary (registry, in English)
VESPA 2.0 is based on an integrative and ecological approach used for the treatment of cognitive dysfunction in patients with MCI or other neurodegenerative disorders.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 20 Feb 2024
- Start date
- 1 Mar 2021
- Primary completion date
- 27 Dec 2022
- Lead sponsor
- IRCCS Centro Neurolesi Bonino Pulejo
- NCT number
- NCT06281314
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 Mar 2021 to the primary completion date, 27 Dec 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Important comorbidities with psychiatric syndromes
- Failure to sign the informed consent
- Clinical conditions that involve vision-related problems.
Other
- Atypical parkinsonisms
Who the study is looking for
- Patients diagnosed with Alzheimer Disease, Multiple Sclerosis, Parkinson Disease
- Severity of mild to moderate cognitive impairment
- Sign informed consent
Age in the registry: 50 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Centro Neurolesi Bonino Pulejo Coordinator of this site? Confirm its status | Messina | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.